Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-PVT: Surgery vs Fibrinolytic Therapy for Prosthetic Heart Valve Thrombosis
NCT01641549Phase 3Unknown
- Sponsor
- AIIMS New Delhi
- Start
- Apr 2017
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of streptokinase in prosthetic heart valve thrombosis (PHVT) (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Complete clinical response at 10 days. Status: unknown.
02
Drugs
streptokinase
03
Conditions
prosthetic heart valve thrombosis (PHVT)
Beyond the preview
Go deeper on NCT01641549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641549.